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Abstract: Bioactivity-guided fractionation of an antimicrobial active extract from twigs of 
Baccharis retusa C. DC. (Asteraceae) yielded the flavanone 5,4'-dihydroxy-7-methoxy-
flavanone (sakuranetin) as responsible for the detected activity. The structure of the 
bioactive compound was established on the basis of spectroscopic data analysis, including 
NMR and MS. Additionally, the structure of a new crystal form of sakuranetin was 
confirmed by X-ray diffratometry. The minimum inhibitory concentrations (MIC) of 
isolated compound were determined against pathogenic yeast belonging to the genus 
Candida (six species), Cryptococcus (two species/four serotypes) and S. cerevisiae BY 
4742 (S288c background) and ranged from 0.32 to 0.63 μg/μL. Our results showed that 
sakuranetin, which structure was fully characterized, could be used as a tool for the design 
of novel and more efficacious antifungal agents. 
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1. Introduction 
Baccharis is an exclusively American genus from Asteraceae and is composed by approximately 
500 species [1]. Several of these species have been used in Brazilian folk medicine as  
anti-inflammatory, antifungal and antimicrobial [2]. Phytochemically, this genus is known to produce 
different classes of natural products, including diterpenes [3,4], triterpenes [5,6], flavonoids [7,8], and 
trichothecenes [8]. Previously, we have investigated the composition of leaves from B. retusa in which 
were isolated several flavonoids [9], including some that displayed antiparasitic [10,11] and  
anti-inflammatory activities [12]. In this paper, we report the bioactivity-guided fractionation of 
antimicrobial extract from twigs of B. retusa, in order to identify the constituent(s) responsible for the 
detected activity. Thus, using several chromatographic procedures, was obtained the flavanone  
5,4'-dihydroxy-7-methoxyflavanone (sakuranetin), which was characterized by NMR and MS analysis. 
Additionally, the structure of a new crystal form of sakuranetin was determined using single crystal  
X-ray analysis. The antimicrobial activity of the isolated compound was tested against species of 
pathogenic yeast belonging to the genus Candida (six species), Cryptococcus, comprising two species (four 
serotypes) and the laboratory standard strain S. cerevisiae BY 4742 (S288c background). Sakuranetin 
showed strong antifungal activity against these opportunistic pathogens and therefore may be considered in 
future studies as a prototype antifungal agent to be applied in the pharmaceutical industry. 
2. Results and Discussion 
The air-dried twigs of Baccharis retusa, defatted with n-hexane, were extracted using EtOH. The 
crude extract was then subjected to successive chromatographic steps using a bioactivity-guided 
fractionation to afford the flavanone sakuranetin as responsible for the antimicrobial activity detected 
in the crude extract. The structure of this compound was fully characterized using NMR and MS as 
well as by X-ray analysis. 
2.1. Chemical Characterization of Sakuranetin by NMR and MS 
The 1H-NMR spectrum (CD3OD, 300 MHz) showed signals at δ 5.32 (dd, J = 13.0 and 3.0 Hz), 
3.08 (dd, J = 17.2 and 13.0 Hz), and at δ 2.73 (dd, J = 17.2 and 3.0 Hz), assigned, respectively, to H-2,  
H-3a, and H-3b [13]. These spectra showed also doublets attributed to H-3'/H-5' at δ 6.83 (J = 8.5 Hz, 
2H) and to H-2'/H-6' at δ 7.26 (J = 8.5 Hz, 2H) as well as one singlet assigned to H-6/H-8 at δ 6.01 
(2H). Additionally was observed one singlet at δ 3.77 (3H), assigned to one methoxyl group linked to 
C-7. 13C and DEPT 135° NMR spectra (CD3OD, 75 MHz) showed peaks at range δ 94–168, which 
were attributed to aromatic carbons C-4a to C8a and C-1' to C-6'. Remaining signals were observed at 
δ 196.5 (C-4), at δ 79.1 (C-2), at δ 42.8 (C-3) and at δ 55.3 (OCH3). These data, associated to 
LRESIMS and correlations observed in the HSQC and HMBC spectra, are consistent with structure of 
5,4'-dihydroxy-7-methoxyflavanone (sakuranetin-Figure 1), confirmed by comparison of spectroscopic 
data with those reported in the literature [11,14].  
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Figure 1. Chemical structure of 5,4'-dihydroxy-7-methoxy-flavanone (sakuranetin). 
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2.2. Structural Crystalline Characterization of Sakuranetin 
In the present study, a monoclinic monohydrate crystal form of sakuranetin hereafter called 
sakuranetin-monohydrate is reported in the space group P21. The structure consists of two independent 
by symmetry flavanone molecules in the asymmetric unit (Z' = 2). Crystal data and structure 
refinement of sakuranetin are presented in Table 1. The ORTEP-3 view of the two flavanones is given 
in Figure 2, which shows that both molecules have disordered aromatic rings.  
Table 1. Crystal data and structure refinement of sakuranetin. 
Empirical Formula 2 (C16H14O5·H2O) 
Formula weight 602.53 
Temperature/K 120(1) K 
Wavelength/Å 1.54180 
Crystal system Monoclinic 
Space group P21 
Unit cell dimensions/Å and ° a = 4.825(5), b = 13.978(5), c = 21.077(5) 
 β = 91.091(5) 
Volume/Å3 1421.3(16) 
Z/Z' 4/2 
Density (calculated)/Mg.m−3 1.422 
Absorption coefficient/mm−1 0.921 
F(000) 640 
Crystal size 0.28 × 0.14 × 0.02 mm3 
Theta range for data collection 4.20 to 63.27° 
Index ranges −5 ≤ h ≤ 3, −15 ≤ k ≤ 15, −24 ≤ l ≤ 23 
Reflections collected 4538 
Independent reflections 3241 [R(int) = 0.0269] 
Completeness to theta = 63.27° 84.1% 
Refinement method Full-matrix least-squares on F2 
Data/restraints/parameters 3241/1/395 
Goodness-of-fit on F2 1.040 
Final R index [I > 2 sigma(I)] R1 = 0.0609, wR2 = 0.1601 
R index (all data) R1 = 0.0917, wR2 = 0.1816 
Largest diff. peak and hole/e.Å−3 0.547 and −0.248 
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Figure 2. ORTEP plot and atom numbering of (a) molecule A and (b) molecule B of 
sakuranetin-monohydrate (S-enantiomer arbitrary chosen). Ellipsoids represent  
50%-probability level. Double-dotted lines represent intramolecular H-bond. Disorder in 
the rings is detailed in light grey and black. Water molecules were omitted for clarity. 
 
(a) 
 
(b) 
The model splitting homologous disordered atoms over two positions with 50% occupancy each was 
found to be the best one. Since there are two different molecules (due to Z' = 2) sakuranetin-monohydrate 
having each one two different conformer (due to disorder showed in Figure 2), the conformers will 
hereafter be referred to Aa = molecule A and conformer a; Ab = molecule A and conformer b;  
Ba = molecule B and conformer a; Bb = molecule B and conformer b. 
There are three previously published crystal structures to sakuranetin. The first reported crystal 
structure is an anhydrous form recrystallized from synthetic product [space group P21/c; cell 
parameters a = 13.172(1), b = 5.660(1), c = 18.101(2) Å, β = 97.28(2), V = 1338.6(4) Å3] [15]. Since 
the anhydrous form consists of a chiral molecule crystallized in a centrosymmetric space group, its 
crystal structure is an equimolar mixture of a pair of enantiomers in a well-defined arrangement 
(racemic crystal). This form will hereafter be referred to as anhydrous sakuranetin. Another crystal 
structure of a dihydrate form of sakuranetin was described [space group P212121; cell parameters  
a = 5.0869(10), b = 9.4622 (19), c = 32.318 (7) Å, β = 97.28(2), V = 1555.6(5) Å3] [16]. Recently it 
was reported a monoclinic lattice form of sakuranetin, space group P21/c with a = 12.8531(12),  
b = 5.7141(3), c = 18.0355(12) Å, β = 97.333(8), V = 1313.77(16) Å3, Z = 4, Mr = 286.27, C16H14O5, 
μ(MoKα) = 0.108 mm−1, Dc = 1.447 g/cm3, F(000) = 600, the final R = 0.0350 and wR = 0.0859 for 
2571 independent reflections (Rint = 0.0246) [17].  
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Despite not establishing the absolute configuration of the dihydrate form by the Flack methods, 
other authors [16] describe it as being the S enantiomer of sakuranetin, hereafter referred as 
sakuranetin-dihydrate.  
In Figure 3 the sakuranetin-anhydrous and sakuranetin-dihydrate structures are superimposed 
themselves in a capped stick fashion. The overlay of molecular backbones clearly shows the 
conformational similarity between homologous atoms, except to the hydroxyl hydrogen atoms of the 
hydroxyphenyl group, in which, the H atoms points to up and to down in sakuranetin-anhydrous and 
sakuranetin-dihydrate, respectively. Since there is no significant difference in terms of non-hydrogen 
atoms comparing the intramolecular structures of the previously determined phases of sakuranetin, 
hereafter sakuranetin-dihydrate will be used in the intramolecular comparisons with the four 
conformers determined for sakuranetin-monohydrate. 
Figure 3. Superimposed structures for the sakuranetin-anhydrous and sakuranetin-dihydrate forms. 
 
Table 2 gives the four torsion angles about the bonds by which the hydroxyphenyl group links the 
chromane ring. It is observed that equivalent conformers in sakuranetin-monohydrate present similar 
torsional angles: Aa ≈ Ba and Ab ≈ Bb. As already shown in Figure 3, the intermolecular geometries of 
the previously determined structures are very similar, which is corroborated comparing their 
homologous dihedral angles (Table 2). Additionally, Table 2 shows that the conformers b (either Ab or 
Bb) are more similar to the previously determined structures than the conformers a (either Aa or Ba).  
Table 2. Torsion angles (°) about the bonds by which the hydroxyphenyl group links the 
chroman rings considering all molecules as S-enantiomer. 
Torsion 
Angle 
(I)-Anhydrous † (I)-Dihydrate † 
(I)-Monohydrate 
Molecule A 
(I)-Monohydrate 
Molecule B 
   conformer a conformer b conformer a conformer b 
φ1 −66.43 −66.13 −41.04 −82.46 −46.04 −78.78 
φ2 111.35 112.62 137.70 106.53 126.89 100.64 
φ3 56.27 56.07 85.38 43.96 76.62 43.89 
φ4 −125.94 −125.19 −95.89 −127.05 −110.45 −136.69 
φ1 = O4-C10-C11-C16; φ2 = O4-C10-C11-C12; φ3 = C9-C10-C11-C16; φ4 = C9-C10-C11-C12. The 
homologous atoms to O4, C10, C11, C12, and C16 in Molecule B are respectively O9, C26, C27, C28, and 
C32. † [15,16]. 
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Figure 4a,b overlay the conformers Aa with Ba and conformer Ab with Bb, respectively, showing the 
similarity of the homologous atoms. Figure 4c overlays sakuranetin-monohydrate (conformer Ab) with 
sakuranetin-dihydrate, which shows that the conformers of sakuranetin-monohydrate are geometrically 
more similar to the two previously determined forms. 
Another intramolecular difference that deserves comment comparing sakuranetin-monohydrate with 
the previously reported structures is the conformation of the methoxyl groups. Figure 4c shows that the 
methoxyl groups have opposite geometries when sakuranetin-monohydrate and sakuranetin-dihydrate 
are superimposed. 
Figure 4. Superimposed structures for: (a) conformers Aa + Ba of sakuranetin-monohydrate; 
(b) conformers Ab + Bb of sakuranetin-monohydrate; and (c) conformers Ab of  
sakuranetin-monohydrate + sakuranetin-dihydrate. Hydrogen atoms were omitted for clarity. 
[Color legend: light grey = Aa and Ab; dark grey = Ba, Bb and sakuranetin-dihydrate]. 
(a) 
 
(b) 
(c) 
The sakuranetin-monohydrate was analyzed through MOGUL [18], a knowledge base that take a 
molecule submitted either manually or by another computer program via an instruction-file interface 
and perform substructure searches of the Cambridge Structural Database (CSD) [19] for, typically, all 
its bond, angles and torsion angles. This study showed that the bonds C8–O2 (1.26(1) Å) and C25–O6 
(1.28(1) Å) in molecules A and B respectively, are larger than expected (1.22(2) Å) when compared to 
similar fragments of molecules deposited in the CSD. This geometric feature is due to the presence of 
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strong intramolecular hydrogen bonds O1–H1 O2 in Molecule A and O6–H6 O7 in Molecule B 
(Figure 2 and Table 3). 
Table 3. Hydrogen bond angles (°) and distances (Å). The characters “D” and “A” refer to 
hydrogen bond donor and acceptor. 
D–H–A d (D–H) d (H–A) d (D–A) <(DHA) 
O1-H1...O2 0.82 1.90 2.632(9) 147.7 
O6-H6...O7 0.82 1.89 2.622(9) 148.8 
O5-H5...O12 i 0.82 2.18 2.97(1) 161.5 
O10-H10a...O11 iv 0.82 2.18 2.97(1) 161.5 
O12-H12c...O1 1.056(6) 1.783(6) 2.839(9) 179.5(5) 
O12-H12d...O5 iv 0.993(6) 1.632(7) 2.625(9) 179.6(5) 
O11-H11b...O6 1.096(5) 1.830(6) 2.926(8) 179.6(4) 
O11-H11a...O10 i 1.105(6) 1.826(7) 2.93(1) 179.9(4) 
O1-H1...O7 vii 0.82 2.41 2.87(1) 116.3 
O6 vii-H6...O2 0.82 2.41 2.87(1) 116.3 
Symmetry transformations used to generate equivalent atoms (as Figures 5 and 6): (i) x, y − 1, z; (iv) x + 1, 
y + 1, z; (vii) x + 1, y, z. 
Taking in account the whole geometry (intra and intermolecular structures) of  
sakuranetin-monohydrated, it is clearly observed a pseudo-symmetry phenomenon. This effect is not 
uncommon, being 27% of the structures with Z' > 1 showing approximate symmetry elements [20]. 
The statistical analysis and systematic absences indicate two possible space groups with 2 mL aue 
symmetry, P21 or P21/m, with 83.1% of certain for the later. However, it was impossible to solve a 
reasonable structure in the centrosymmetric space group P21/m and then P21 was tried giving a 
satisfactory structure determination. In fact, examining the two crystallographically independent 
molecules in the asymmetric unit solved in P21 space group, was observed that they are related by a 
pseudo-inversion center, i.e., only part of the two individuals molecules are related by inversion center 
(Figure 5). Indeed, a centrosymmetric space group is impossible because the isolated chiral molecule is 
enantiopure/homochiral.  
Figure 5. Details of molecules A and B in sakuranetin-monohydrate related to the  
pseudo-inversion center. Solid green lines show atoms related by the inversion center 
(black point). The inversion symmetry is forbidden for the stereogenic atoms C10 and C26 
in the homologous chromane rings (highlighted by circles). 
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The packing of sakuranetin-monohydrate phase is mainly stabilized by intermolecular classical 
hydrogen bonds. Figure 6 shows 2D networks parallel to ab plane formed by A molecules. In this 
layer, the oxygen atom (O12) of molecule of water acts as H bond donor to O1 and O5 (from hydroxyl 
groups) and also as H bond acceptor from O5 [see symmetry codes in Figure 5 and Table 2], forming a 
supramolecular structure with ܴలలሺଷସሻ assemblies [21].  
Figure 6. A section of the supramolecular 2D assembly of sakuranetin-monohydrate 
(Molecule A), projected onto (001). The chains propagation along [100] and [010] are evident. 
Hydrogen bonds are shown as dashed lines. Displacement ellipsoids are drawn at the 30% 
probability level. H of carbon atoms were omitted for clarity. [Symmetry codes: (i) x, y − 1, z; 
(ii) −x, −y, z; (iii) x, y + 1, z; (iv) x + 1, y + 1, z; (v) x − 1, y + 1, z; (vi) x − 1, y, z]. 
 
Similar layers also parallel to ab plane are formed by B molecules. An AABBAA fashion staking is 
formed along [001] (Figures 7 and 8).  
Figure 7. The crystal packing illustration of sakuranetin-monohydrate onto the bc plane. 
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Figure 8. The crystal packing illustration of sakuranetin-monohydrate onto the ac plane. 
 
Figure 9 shows that neighbor layers AB (or BA) are themselves linked by intermolecular H bonds. 
It is observed that O1 is H bond donor either to O2 (intra) or O7 (intermolecular), whereas O6 is H 
bond donor either to O7 (intra) or O2 (intermolecular). A square-like ring with an ܴమమሺସሻ assembly is 
formed containing two bifurcated H bonds. The hydrogen bonds geometries are given in Table 2. 
Figure 9. A section of the supramolecular double chain of sakuranetin-monohydrate 
projected onto (104) with double chain propagation along [010]. Hydrogen bonds are 
shown as dashed lines. Displacement ellipsoids are drawn at the 30% probability level. H 
of carbon atoms were omitted for clarity. [Symmetry code: (vii) x + 1, y, z]. 
 
As observed in Figure 8, which shows the packing of the monohydrate phase onto plane bc, that 
green (Molecules A) and blue (Molecules B) chains formed along [010] are, as expected, related to the 
21-fold screw axis parallel to unit cell b axis of the P21 space group. Is it interesting to note that green 
and blue chains are apparently related to a glide plane (glide c) normal to the unit cell b axis. This is of 
course a not real crystallographic symmetry because the homochirality discussed above, but shows that 
the packing analysis point out to a pseudo-symmetry closer to P21/c than P21/m suggested to the 
systematic absences analysis. 
2.3. Antifungal Sensibility Test 
In a preliminary screen, crude extract, fractions A–F and B1–B7 (see Experimental) were tested by 
disk diffusion assay, using fluconazole (100 µg) as positive and sterile water as negative controls. 
Crude extract, fractions B and B3 produced growth inhibition at 100 µg per disk for all tested 
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microorganisms. In order to determine the antimicrobial activity of sakuranetin, isolated from bioactive 
fraction B3, the minimum inhibitory concentrations (MIC-concentration range: 0.003–1.0 μg/μL) were 
determined. As showed at Table 4, sakuranetin exhibited between 98% and 99% of growth inhibition 
at 0.63 µg/µL to all tested Candida strains, except for C. albicans, which was more sensitive to 
sakuranetin at 0.32 µg/µL (99% inhibition). Cryptococcus species displayed similar behavior:  
C. neoformans serotype A (var. grubbii) strain and C. gatti (R265) were inhibited at 99% and 97% at  
0.32 µg/µL of sakuranetin, respectively. These two strains maintained an inhibition rate reaching 15% 
and 17% growth inhibition at 0.04 µg/µL, indicative of moderate growth. This result suggests they are 
more sensitive than other Cryptococcus and Candida strains. C. gatti (NIH 312) and S. cerevisiae 
showed 97% and 99% inhibition at 0.32 µg/µL, respectively, which is similar to what was detected for 
C. albicans. The most sensitive strains was C. neoformans serotype D (JEC21) which had 98% 
inhibition at 0.08 µg/µL. C. neoformans serotype A and D are the most clinical relevant types, 
therefore, these results will be important regarding future treatment.  
Table 4. Target strains used for antifungal activity assays and MIC results to sakuranetin. 
Species Designation Source * MIC (µg/µL) Sakuranetin ** 
Candida dubliniensis ATCC 7978 ATCC 0.63 (99%) 
Candida tropicalis ATCC 13803 ATCC 0.63 (98%) 
Candida glabrata ATCC 90030 ATCC 0.63 (99%) 
Candida parapsilosis Clinical isolate 68 CBMAI 0.63 (98%) 
Candida krusei Clinical isolate 9602 CBMAI 0.63 (99%) 
Candida albicans CBMAI 560 CBMAI 0.32 (99%) 
Cryptococcus neoformans KN99α (serotype A) LIMIc 0.32 (99%) 
Cryptococcus gattii R265 (serotype B) LIMIc 0.32 (97%) 
Cryptococcus gattii NIH312 (serotype C) LIMIc 0.32 (97%) 
Cryptococcus neoformans JEC21 (serotype D) LIMIc 0.08 (98%) 
Saccharomyces cerevisiae BY4742 LIMIc 0.32 (99%) 
* ATCC: American Type Culture Collection; CBMAI: Centro Brasileiro de Microrganismos Ambientais e 
Industriais; LIMic collection: Laboratório de Interações Microbianas-UNIFESP. ** Percentages in 
parenthesis represent the growth inhibition compared to the no drug control fluconazole (100% growth). 
The antifungal activity of sakuranetin was previously reported against phytopathogenic Cladosporium 
sp. [22] and against clinical strains of Trichophyton rubrum and T. mentagrophytes [23]. In this work, 
purified sakuranetin displayed also a good potential as antifungal agents for opportunistic pathogenic 
yeasts. These results indicated that sakuranetin could be used as a tool for the design of novel and more 
efficacious antifungal agents. 
3. Experimental 
3.1. General Experimental Procedures 
1H, 13C, DEPT 135°, HSQC, and HMBC NMR spectra were recorded at 300 MHz (1H nucleus) and 
75 MHz (13C nucleus) in a Bruker Ultrashield 300 Advance III spectrometer using CD3OD (Aldrich) 
as solvent and internal standard. Chemical shifts are reported in δ units (ppm) and coupling constants (J)  
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in Hz. LRESIMS was measured in Micromass Platform mass spectrometer, operating at positive mode. 
Flash silica gel (Merck, 230–400 mesh) and Sephadex LH-20 (Aldrich) were used for column 
chromatographic separation, while silica gel 60 F254 (Merck) was used for analytical (0.25 mm) and 
preparative (1.00 mm) TLC. Crude extract from twigs of B. retusa was prepared using a Dionex 350 
Accelerated Solvent Extraction (ASE) at room temperature.  
3.2. Plant Material 
Baccharis retusa DC. twigs were collected in Campos do Jordão, SP, Brazil, in October 2010 and 
were identified by Oriana A. Fávero. Voucher specimen has been deposited at Herbarium of Instituto 
de Botânica-SEMA, São Paulo, SP, Brazil. 
3.3. Extraction and Isolation 
Dried and powdered twigs of B. retusa (150 g) were exhaustively defatted with n-hexane than 
extracted with EtOH affording 7 g of a syrupy extract, after solvent evaporation under reduced 
pressure. Part of this extract (4 g) was subjected to flash column chromatography (silica gel) eluted 
with increasing amounts of MeOH in CH2Cl2 to give six fractions of 200 mL each: A (95% of CH2Cl2, 
114 mg), B (90% of CH2Cl2, 844 mg), C (80% of CH2Cl2, 325 mg), D (70% of CH2Cl2, 547 mg),  
E (50% of CH2Cl2, 663 mg), and F (100% of MeOH, 448 mg), being the antimicrobial activity 
detected in fraction B. Part of this material (500 mg) was subjected to Sephadex LH-20 column 
chromatography eluted with CHCl3:MeOH 1:1. This procedure afforded seven fractions (B1–B7), in 
which antimicrobial activity was detected at B3 (214 mg). This fraction was than purified by prep. 
TLC (silica gel) eluted with CH2Cl2/MeOH 95:5 to afford 93 mg of sakuranetin.  
3.4. 5,4'-Dihydroxy-7-methoxyflavanone (sakuranetin) 
1H-NMR (300 MHz, CD3OD) δH: 7.26 (d, J = 8.5 Hz, H-2'/H-6'), 6.83 (d, J = 8.5 Hz, H-3'/H-5'), 6.01 
(s, H-6/H-8), 5.32 (dd, J = 13.0 and 3.0 Hz, H-2), 3.77 (s, OCH3-7), 3.08 (dd, J = 17.2 and 13.0 Hz,  
H-3a), 2.73 (dd, J = 17.2 and 3.0 Hz, H-3b). 13C-NMR (75 MHz, CD3OD) δC: 196.5 (C-4), 168.0 (C-4'), 
163.6 (C-7), 163.0 (C-5), 157.4 (C-8a), 129.0 (C-1'), 127.7 (C-2'/C-6'), 127.6 (C-6), 115.3 (C-3'/C-5'), 
102.8 (C-4a), 93.9 (C-8), 79.1 (C-2), 55.3 (OCH3), 42.8 (C-3). LRESIMS m/z 287 [M+H]+.  
3.5. X-ray Crystallography 
Colorless plate-like crystals of sakuranetin were obtained by slow evaporation of MeOH. A  
well-shaped and suitably-sized single crystal was selected for the X-ray diffraction structure 
determination experiment. The X-ray intensity data were collected at 120 K on a Gemini-Oxford 
Diffractometer, using MoKα graphite monochromated radiation. The programs CrysAlis CCD and 
CrysAlis RED [24] were used for data collection, cell refinement and data reduction. The structure was 
solved by direct methods using the software Sir-92 [25] and the refinement was carried out using 
SHELXL-2013 [26]. The carbon and oxygen atoms of the molecule were clearly solved and full matrix 
least-squares refinement of these atoms with anisotropic thermal parameters was carried on, except for 
the disordered C atoms that were refined with isotropic thermal parameters. Hydrogen atoms on 
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carbon and oxygen atoms were positioned stereochemically and were refined with fixed individual 
displacement parameters [Uiso (H) = 1.5 Ueq (C or O) for methyl and hydroxyl groups or 1.2 Ueq (C) 
for methine and methylene groups] using a riding and rotating group model (for methyl and hydroxyl 
groups), with C-H bond lengths of 0.96, 0.97, 0.98 and 0.82 Å for methyl, methine, methylene and 
hydroxyl groups, respectively. The hydrogen atoms from water molecule were located by difference 
Fourier synthesis and were kept as rigid group together with its respective oxygen atoms during the 
subsequent refinements. WINGX software was used to analyze and prepare the data for  
publication [27]. Molecular graphics were prepared using ORTEP-3 for Windows [28] and  
Mercury [29]. Since the most electron-rich atom is the oxygen atom, which does not have an 
anomalous scattering large enough (using MoKa radiation), it was not possible to determine the 
enantiomer present using the Flack method [30]. In this way, the S-enantiomer was chosen during the 
crystal structure determination/refinement using the same absolute structure determined for 
sakuranetin previously described in literature [16,31,32]. Crystallographic data for the structural 
analysis of the compound discussed here has been deposited at the Cambridge Crystallographic Data 
Centre as a supplementary publication under number CCDC 998334. Copies of the data can be 
obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge CB12 1EZ, UK  
[fax: +44 1223 336033 or e-mail: deposit@ccdc.cam.ac.uk]. 
3.6. Disk Diffusion Assay 
Antimicrobial activity was initially evaluated by the disk diffusion method according to CLSI  
(M2-A8) former National Committee for Clinical Laboratory Standards (NCCLS) with the following 
modifications. In brief, thin agar plates were prepared with 10 mL of yeast medium YEPD. Three 
milliliters of liquid cultures were grown at 30 °C with aeration (150 rpm) overnight on YEPD and a 
top agar was prepared by mixing 100 µL of each culture with 10 mL of soft agar medium for confluent 
plates (YEPD) and poured on top of the thin agar (2% agar). Sterilized 6 mm filter paper disks were 
then impregnated with 5 µL of extracts, fractions or sakuranetin. The disks were placed on top of agar 
plates and incubated at 30 °C for 24 or 48 h. Fluconazole was used as positive control and negative 
control was prepared by impregnating the paper disks with the same amount of DMSO used to dilute 
the samples. All tests were performed in triplicate. The inhibition zone (IZ) was determined by 
measuring the whole halo diameter divided by the disk size (6 mm) [33]. 
3.7. Minimum Inhibitory Concentration 
Microdilution tests were conducted in sterile 96 well micro titer plates in a total volume of 100 µL 
according to the CLSI Protocol (M27–A2) former National Committee for Clinical Laboratory 
Standards (NCCLS), with the following modifications: microorganisms were cultured in test tubes 
overnight at 30 °C in 3 mL medium YEPD in a rotary shaker (150 rpm). The cultures were diluted and 
adjusted to (1–2) × 102 CFU/mL, which was confirmed by viability counts on YEPD plates (100 µL of 
diluted cells). Samples diluted in DMSO were serial diluted two-fold and tested. A sterilization control 
containing medium only (negative control) and growth control containing cell and DMSO (1%) were 
included as controls. Micro titer plates were then incubated at 30 °C for 24 or 48 h. Finally, the 
absorbance at 600 nm was measured in a plate reader (MT-960, Logen) and the minimum inhibitory 
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concentration was considered the lowest concentration at which inhibition was at least 90% of the no 
drug control and visual growth inhibition was detected. All wells were stained with the vital staining 
rezasurin (0.005% in sterile PBS buffer) in order to improve visual inspection. All tests were 
performed in duplicates [33,34]. 
4. Conclusions 
In conclusion, the flavanone 5,4'-dihydroxy-7-methoxyflavanone (sakuranetin) was isolated from 
twigs of B. retusa and identified by comparison of their NMR and MS data with those reported in the 
literature. In addition, the stereochemistry and crystal packing of sakuranetin was elucidated by single 
crystal X-ray diffratometry. This compound was also evaluated for its inhibitory activity against 
pathogenic yeast belonging to the genus Candida, Cryptococcus and S. cerevisiae. The obtained data 
showed that sakuranetin exhibited the strongest antimicrobial activity (MIC values ranging from  
0.32 to 0.63 μg/μL) suggesting that this compound could be used as scaffolds for the design of novel 
antifungal derivatives. 
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